Adherence to taking medication is essential for patients with chronic diseases such as Type 2 Diabetes Mellitus (T2DM). There have been many studies about the association between medication adherence and HbA1c levels, but few have used Adherence Refills and Medications Scale (ARMS) questionnaire and Proportion of Days Covered (PDC) method to measure adherence in Indonesian population. The aim of this study were to assess the association of medication adherence to HbA1c levels and compare two methods of adherence measurements. This research was conducted at Pasar Minggu Public Health Center, Jakarta using a cross-sectional design. The adherence assessment was conducted using a validated Indonesian version of the ARMS questionnaire and compared to the pharmacy refill adherence method using the PDC calculation. One hundred twenty-seven T2DM patients (75.6% female) with mean age of 58.69 years were recruited. The proportion of adhere patients as measured by ARMS was only 39.4% (50/127). Meanwhile, the proportion of adhere patients as measured by PDC was 77.2% (98/127). Adherence by both measurement showed significant associations with HbA1c <7% (ARMS, OR 4.000 (95% CI 1.705 – 9.386), p = 0.002; PDC, OR 5.674 (95% CI 1.266 – 25.438), p = 0.024). After controlled by covariates, the result remained significant (ARMS, aOR 4.281 (95% CI 1.785 – 10.267, p = 0.001; PDC, aOR 5.83 (95% CI 1.287 – 26.405), p = 0.022). Adherence and HbA1c levels was significantly associated even after controlling covariates. ARMS and PDC generated different proportions of adhere patients and may indicate the need of combining the two methods in measuring adherence.


Abd Elaaty, T. A., Ismail, A. A., Sheshtawy, H. A., Sultan, E. A., & Ebrahim, M. G. (2019). Assessment of comorbid mild cognitive impairment and depression in patients with type 2 diabetes mellitus. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 13(3), 1759–1764. https://doi.org/10.1016/j.dsx.2019.03.012

Al-Hassany, L., Kloosterboer, S. M., Dierckx, B., & Koch, B. C. P. (2019). Assessing methods of measuring medication adherence in chronically ill children–A narrative review. Patient Preference and Adherence, 13, 1175–1189. https://doi.org/10.2147/PPA.S200058

American Diabetes Association. (2014). Standards of medical care in diabetes 2014. Diabetes Care, 37(October 2013), 14–80. https://doi.org/10.2337/dc14-S014

Anghel, L. A., Farcas, A. M., & Oprean, R. N. (2019). An overview of the common methods used to measure treatment adherence. Medicine and Pharmacy Reports, 92(2), 117–122. https://doi.org/10.15386/mpr-1201

Avorn, J., Monette, J., Lacour, A., Bohn, R. L., Monane, M., Mogun, H., & LeLorier, J. (1998). Persistence of use of lipid-lowering medications: A cross-national study. Journal of the American Medical Association, 279(18), 1458–1462. https://doi.org/10.1001/jama.279.18.1458

Bazargan, M., Smith, J., Yazdanshenas, H., Movassaghi, M., Martins, D., & Orum, G. (2017). Non-adherence to medication regimens among older African-American adults. BMC Geriatrics, 17(1), 1–12. https://doi.org/10.1186/s12877-017-0558-5

Benner, J. S., Glynn, R. J., Mogun, H., Neumann, P. J., Weinstein, M. C., & Avorn, J. (2002). Long-term persistence in use of statin therapy in elderly patients. Journal of the American Medical Association, 288(4), 455–461. https://doi.org/10.1001/jama.288.4.455

Cahyadi, H., Prayitno, A., & Setiawan, E. (2015). Reliability and validity of adherence to Refill and Medication Scale (ARMS) in Indonesian geriatric population with diabetes. Retrieved April 14, 2021, from IAGG Asia/Oceania 2015 website: http://repository.ubaya.ac.id/id/eprint/34101

Cain, C. J., Meisman, A. R., Drucker, K., Isaac, E. I., Verma, T., Gri, J., & Rohan, J. M. (2020). When multiple objective measures of medication adherence indicate incongruent adherence results : An example with pediatric cancer. International Journal of Environmental Research and Public Health, 17, 1–8. https://doi.org/doi:10.3390/ijerph17061956

Doggrell, S. A., & Warot, S. (2014). The association between the measurement of adherence to anti-diabetes medicine and the HbA1c. International Journal of Clinical Pharmacy, 36(3), 488–497. https://doi.org/10.1007/s11096-014-9929-6

Ginting, H., Näring, G., Veld, W. M. Van Der, & Srisayekti, W. (2013). Validating the beck depression inventory-II in Indonesia ’ s general population and coronary heart disease patients. International Journal of Clinical and Health Psychology, 13(3), 235–242. https://doi.org/10.1016/S1697-2600(13)70028-0

Grenard, J. L., Munjas, B. A., Adams, J. L., Suttorp, M., Maglione, M., Mcglynn, E. A., & Gellad, W. F. (2011). Depression and medication adherence in the treatment of chronic diseases in the United States : A meta-analysis. Journal General Internal Medicine, 10, 1175–1182. https://doi.org/10.1007/s11606-011-1704-y

Gupta, S., Jain, U., & Chauhan, N. (2017). Laboratory diagnosis of HbA1c: A Review. Journal of Nanomedicine Research, 5(4), 1–10. https://doi.org/10.15406/jnmr.2017.05.00120

Hammad, M. A., Azri, D., Noor, M., Azhar, S., & Sulaiman, S. (2017). The effect of patient’s adherence on HbA1c control. Sterling Academic Journals, 01(01), 30–35.

Husein, N., Lumempouw, S., & Ramli, Y. (2010). Uji validitas dan reliabilitas montreal cognitive assessment versi Indonesia ( MoCA-Ina ). Neurona, 27(4).

International Diabetes Federation. (2021). IDF Diabetes Atlas (10th ed.; E. J. Boyko, D. J. Magliano, S. Karuranga, L. Piemonte, P. Riley, P. Saeedi, & H. Sun, Eds.). Retrieved from https://diabetesatlas.org/

Jaam, M., Ibrahim, M. I. M., Kheir, N., Hadi, M. A., Diab, M. I., & Awaisu, A. (2017). Assessing prevalence of and barriers to medication adherence in patients with uncontrolled diabetes attending primary healthcare clinics in Qatar. Primary Care Diabetes, 12(2), 116–125. https://doi.org/10.1016/j.pcd.2017.11.001

Krapek, K., King, K., Warren, S. S., George, K. G., Caputo, D. A., Mihelich, K., … Lubowski, T. J. (2004). Medication adherence and associated hemoglobin A 1c in type 2 diabetes. Annals of Pharmacotherapy, 38(9), 1357–1362. https://doi.org/10.1345/aph.1D612

Kripalani, S., Risser, J., Gatti, M. E., & Jacobson, T. A. (2009). Development and evaluation of the Adherence to Refills and Medications Scale ( ARMS ) among low-literacy patients with chronic disease. Value in Health, 12(1), 118–123. https://doi.org/10.1111/j.1524-4733.2008.00400.x

Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H. (2021). Factors contributing to medication adherence in patients with a chronic condition : A scoping review of qualitative research. Pharmaceutics, 13(7), 1–41. https://doi.org/10.3390/pharmaceutics13071100

Lang, V. B., & Marković, B. B. (2016). Prevalence of comorbidity in primary care patients with type 2 diabetes and its association with elevated HbA1c : A cross-sectional study in Croatia. Scandinavian Journal of Primary Health Care, 34(1), 66–72. https://doi.org/10.3109/02813432.2015.1132886

Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., … Wenger, N. S. (2001). A Comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968–977. https://doi.org/10.7326/0003-4819-134-10-200105150-00011

Llabre, M. M., Weaver, K. E., Duran, R. E., Antoni, M. H., Mcpherson-baker, S., Pharm, D., & Schneiderman, N. (2006). A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults. AIDS Patient Care and STDs, 20(10), 701–711. https://doi.org/10.1089/apc.2006.20.701

Lomper, K., Chabowski, M., Chudiak, A., Białoszewski, A., Dudek, K., & Jankowska-Polanska, B. (2018). Psychometric evaluation of the polish version of the Adherence to Refills and Medications Scale ( ARMS ) in adults with hypertension. Dove Press, 12, 2661–2670. https://doi.org/10.2147/PPA.S185305

Luijks, H., Biermans, M., Bor, H., Weel, C. Van, Lagro-janssen, T., Graw, W. de, & Schermer, T. (2015). The effect of comorbidity on glycemic control and systolic blood pressure in type 2 diabetes : A cohort study with 5 year follow- up in primary care. PLoS ONE, 1–18. https://doi.org/10.1371/journal.pone.0138662

Lunghi, C., Zongo, A., Moisan, J., Gregoire, J., & Guenette, L. (2017). The impact of incident depression on medication adherence in patients with type 2 diabetes. Diabetes and Metabolism Journal, 43, 521–528. https://doi.org/10.1016/j.diabet.2017.07.003

Mehta, R. L., Davies, M. J., Ali, S., Taub, N. A., Stone, M. A., Baker, R., … Khunti, K. (2011). Association of cardiac and non-cardiac chronic disease comorbidity on glycaemic control in a multi-ethnic population with type 1 and type 2 diabetes. Postgraduate Medicine, 87, 763–768. https://doi.org/10.1136/postgradmedj-2011-130298

Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67–74. Retrieved from http://www.jstor.org/stable/3764638

Nanayakkara, N., Curtis, A. J., Heritier, S., Gadowski, A. M., Pavkov, M. E., Kenealy, T., … Mohan, V. (2021). Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications : systematic review and meta-analyses. Diabetologia, 64, 275–287. https://doi.org/doi.org/10.1007/s00125-020-05319-w

Nasreddine, Z. S., Phillips, N. A., Bedirian, V., Charbonneau, S., Whitehead, V., Collin, I., … Chertkow, H. (2005). The montreal cognitive assessment, MoCA : A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x

Nichols, G. A., Rosales, A. G., Kimes, T. M., Tunceli, K., Kurtyka, K., & Mavros, P. (2016). The change in HbA1c associated with initial adherence and subsequent change in adherence among diabetes patients newly initiating metformin therapy. Journal of Diabetes Research, 2016, 1–5. https://doi.org/10.1155/2016/9687815

Ogston, S. A., Lemeshow, S., Hosmer, D. W., Klar, J., & Lwanga, S. K. (1991). Adequacy of sample size in health studies. Biometrics, 47(1), 347. https://doi.org/10.2307/2532527

Okumura, P. C., Okumura, L. M., Reis, W., Godoy, R., Cata-Preta, B., de Souza, T., … Correr, C. (2016). Comparing medication adherence tools scores and number of controlled diseases among low literacy patients discharged from a Brazilian cardiology ward. International Journal of Clinical Pharmacy, 38, 1362–1366. https://doi.org/10.1007/s11096-016-0390-6

Pandey, A., Raza, F., Velasco, A., Brinker, S., Ayers, C., Das, S. R., … Vongpatanasin, W. (2015). Comparison of morisky medication adherence scale with therapeutic drug monitoring in apparent treatment – resistant hypertension. Journal of the American Society of Hypertension, 9(6), 420-426.e2. https://doi.org/10.1016/j.jash.2015.04.004

Patel, S., Abreu, M., Tumyan, A., Adams-Huet, B., Li, X., & Lingvay, I. (2019). Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study. BMJ Open Diabetes Research and Care, 7(1). https://doi.org/10.1136/bmjdrc-2019-000761

Piette, J. D., Richardson, C., & Valenstein, M. (2004). Addressing the needs of patients with multiple chronic illnesses: The case of diabetes and depression. The American Journal of Managed Care, (February), 152–162.

Sherwani, S. I., Khan, H. A., Ekhzaimy, A., Masood, A., & Sakharkar, M. K. (2016). Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomarker insights, 11, 95–104. https://doi.org/10.4137/BMI.S38440

Sonmez, A., Tasci, I., Demirci, I., Haymana, C., Barcin, C., Aydin, H., … Gul, K. (2020). A cross-sectional study of overtreatment and deintensification of antidiabetic and antihypertensive medications in diabetes mellitus : The TEMD Overtreatment Study. Diabetes Ther, 11, 1045–1059.https://doi.org/10.1007/s13300-020-00779-0

World Health Organization. (2003). Adherence to Long-term Therapies World Health Organization 2003 (1st ed.; E. Sabaté, Ed.). Geneva: World Health Organization.

Yap, A. F., Thirumoorthy, T., & Kwan, Y. H. (2016). Medication adherence in the elderly. Journal of Clinical Gerontology & Geriatics, 7(2), 64–67. https://doi.org/10.1016/j.jcgg.2015.05.001

Ye, M., Vena, J. E., Johnson, J. A., Shen-tu, G., & Eurich, D. T. (2022). Anti-hyperglycemic medication adherence and health services utilization in people with diabetes : A longitudinal study of alberta’s tomorrow project. Dove Press, 16(June), 1457–1467. https://doi.org/10.2147/PPA.S362539



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.